Researchers cross-check blood samples for test in Huo-Yan Laboratory at BGI in Shenzhen yesterday. The company had produced 1.5 million detection test kits for COVID-19 screening in China as of Monday and has completed 360,000 nucleic acid tests. (Story on P2)Courtesy of BGI |